NCT04860206 (PostCovidZRS) is a clinical trial in Covid19, sponsored by Science and Research Centre Koper.

Who is sponsoring NCT04860206?

NCT04860206 is sponsored by Science and Research Centre Koper.

What condition does NCT04860206 study?

NCT04860206 studies Covid19, Respiratory Disease, Walking, Difficulty, Cognitive Decline.

Is NCT04860206 still recruiting?

NCT04860206 is currently completed. Last updated 21 September 2022.

Last reviewed 2022-09-21 · How we verify

NCT04860206: PostCovidZRS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post COVID19 Functional and Cognitive Assessments

Completed Last updated 21 September 2022

What this trial tests

trial in Covid19 in 43 participants. Completed in 30 September 2021.

Timeline

5 January 2021

Primary endpoint
30 September 2021

30 September 2021

Quick facts

Lead sponsor	Science and Research Centre Koper
Status	Completed
Study type	OBSERVATIONAL
Enrollment	43
Start date	5 January 2021
Primary completion	30 September 2021
Estimated completion	30 September 2021
Sites	1 location across Slovenia

Conditions studied

Covid19 — all drugs for Covid19 →
Respiratory Disease — all drugs for Respiratory Disease →
Walking, Difficulty — all drugs for Walking, Difficulty →
Cognitive Decline — all drugs for Cognitive Decline →

Sponsor

Science and Research Centre Koper

Who can join

Adults 18 to 100, any sex, with Covid19 or Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the proposed study is to evaluate the impact of coronavirus (2019-nCoV), hereafter COVID -19, on patients' loss of functional capacity after completion of hospital treatment. Specifically, the research will focus on examining changes in musculoskeletal, cardiovascular, and respiratory function, as well as motor control. In addition, we aim to evaluate rehabilitation treatments after recovery from COVID -19 and consider additional preventive measures based on previous experience.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up.
Peskar M, Šimunič B, Šlosar L, Pišot S, et al · · 2023 · cited 7× · PMID 37303911 · DOI 10.3389/fpsyg.2023.1141809
Functional characteristics and subjective disease perception in patients with COVID-19 two months after hospital discharge.
Teraž K, Šimunič B, Peskar M, Marusic U, et al · · 2023 · PMID 37546579 · DOI 10.3389/fresc.2023.1209900

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Science and Research Centre Koper trials

Trials by the same sponsor.

NCT06141291 — Bed Rest Study SBI 2023 · NA · completed
NCT05477654 — Motor-cognitive Dual-task in Healthy Older Adults and Early Parkinson's Disease Patients · unknown
NCT05094713 — Effects of Muscle Flossing on Quadriceps Muscle Potentiation · NA · completed
NCT04734808 — EEG Brain Activity At Various Cycling Intensities · NA · unknown
NCT04744597 — Fitt's Law MI Experiment · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04860206 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Science and Research Centre Koper
Last refreshed: 21 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing